Astrocytoma, IDH-Mutant — Trials

Astrocytoma, IDH-Mutant — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06047379	Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis	recruiting	Phase 1 / Phase 2	134	Neonc Technologies, Inc.INDUSTRY	1	Sep 24, 2026	clinicaltrials
NCT07831369	VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma	recruiting	Phase 2	52	Inova Health Care ServicesOTHER	1	Sep 21, 2026	clinicaltrials
NCT07468136	Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas	recruiting	Phase 1 / Phase 2	33	Mayo ClinicOTHER	1	Jun 24, 2026	clinicaltrials
NCT07301268	GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Data updated 5 days agoSource updated Sep 24, 2026source: clinicaltrials